Evidence map›Paper›PMID 19494839›Full record

ArticleLeukemia2009

Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target.

J E Jones, L Wang, P L Kropf, R Duan, D E Johnson

Abstract readLetter
In one paragraph

Article in Leukemia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. CDK6 Inhibition: A Novel Approach in AML Management.International journal of molecular sciences · 2020
    Review
  2. The progress of early growth response factor 1 and leukemia.Intractable & rare diseases research · 2016
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J E Jones
L Wang
P L Kropf
R Duan
D E Johnson

Funding

Opposing Roles for MEK/ERK in Differentiation &LeukemiaR01CA108904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHNSON, DANIEL E · 2005 to 2009
$1.4M
NCI NIH HHS R01 CA108904
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationAntineoplastic AgentsEarly Growth Response Protein 1Gene Expression ProfilingHumansLeukemia, Promyelocytic, AcuteOligonucleotide Array Sequence AnalysisPyrimidinesReverse Transcriptase Polymerase Chain ReactionRNA, Messengersrc-Family KinasesTretinoinTumor Cells, CulturedAG 1879Antineoplastic AgentsEarly Growth Response Protein 1EGR1 protein, humanPyrimidinesRNA, Messengersrc-Family KinasesTretinoin

Identifiers

PMID19494839
PMCPMC2762004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.